ArticleAnnals of translational medicine2017

Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.

Denira Imamovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.